This compound is a quinazoline diamine derivative used as a pharmaceutical intermediate in the manufacture of afatinib impurity standards. It features a dichlorophenyl substituent and a chiral oxolanyl ether group, with a molecular weight of 390.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2044709-79-5
N4-(3-chloro-4-fluorophenyl)-7-(((3S)-tetrahydro-3-furanyl)oxy)-4,6-quinazolinediamine
active pharmaceutical ingredient metabolite
(R)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4,6-diamine
active pharmaceutical ingredient
Desfluoro-N-des(4-dimethylamino-2-en-1-oxo)butyl Afatinib
Afatinib impurity reference standard
(S)-N4-(3,4-Difluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine
Pharmaceutical intermediate for afatinib
6-Amino-4-[(3-chloro-4-fluorophenyl)amino]-7-quinazolinol
pharmaceutical intermediate for afatinib impurities
Methyl 3-((2S,3R)-2-(4-(benzyloxy)phenyl)-1-(4-fluorophenyl)-4-oxoazetidin-3-yl)propanoate
Pharmaceutical intermediate
1-bromo-3,5-dimethoxybenzene
pharmaceutical intermediate
(2S)-2-(9H-Fuoren-9-ylmethoxycarbonylamino)-6-((1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)-3-methylbutylidene)amino)hexanoic acid
Peptide synthesis protected amino acid
4-N-(3,4-dichlorophenyl)-7-[(3S)-oxolan-3-yl]oxyquinazoline-4,6-diamine
BWMFVFPCIQVGNU-NSHDSACASA-N
C1COC[C@H]1OC2=C(C=C3C(=C2)N=CN=C3NC4=CC(=C(C=C4)Cl)Cl)N
—